Mechanism of Apoptotic Cell Death by 2,4,3',5'-Tetramethoxystilbene in Human Promyelocytic Leukemic HL-60 Cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sang-Kwang LEE | - |
dc.contributor.author | Ah-Reum CHAE | - |
dc.contributor.author | 천영진 | - |
dc.date.available | 2019-08-23T03:00:43Z | - |
dc.date.issued | 2007 | - |
dc.identifier.issn | 1976-9148 | - |
dc.identifier.issn | 2005-4483 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/35798 | - |
dc.description.abstract | trans-stilbene ana-logue acting as a potent inhibitor of human cytochrome P450 1B1, induces apoptotic cel death in human cancercells. In the present studies, we report the mechanisms of apoptotic cell death by TMS in human promyelocyticleukemic HL-60 cels. We found that treatment of HL-60 cels with TMS suppresed the cel growth in a con-centration-dependent manner with IC50 value of about 0.8 .M. Imunoblot experiments revealed that DMHS-cfrom mitochondria into the cytosol was significantly increased in response to TMS. TMS caused activation ofcaspase-3 in a concentration-dependent manner and TMS-mediated caspase-3 activation was partially preventedby the caspase inhibitor, zVAD-fmk. Interestingly, we found that the cytoxic efect of anticancer drugs such aspaclitaxel, docetaxel, or etoposide was enhanced in the presence of TMS. Simultaneous treatment with TCDDpresent results indicated that TMS leads to apoptotic cell death in HL-60 cels through activation of caspase-3activity and release of cytochrome c into cytosol. The ability of TMS to increase cytotoxic effect of anticancerdrugs may contribute to its usefulness for cancer chemotherapy.Keywords . Tetramethoxystilbene, HL-60 cells, caspase-3, cytochrome c | - |
dc.format.extent | 5 | - |
dc.publisher | 한국응용약물학회 | - |
dc.title | Mechanism of Apoptotic Cell Death by 2,4,3',5'-Tetramethoxystilbene in Human Promyelocytic Leukemic HL-60 Cells | - |
dc.type | Article | - |
dc.identifier.bibliographicCitation | Biomolecules & Therapeutics, v.15, no.3, pp 145 - 149 | - |
dc.identifier.kciid | ART001197666 | - |
dc.description.isOpenAccess | N | - |
dc.citation.endPage | 149 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 145 | - |
dc.citation.title | Biomolecules & Therapeutics | - |
dc.citation.volume | 15 | - |
dc.publisher.location | 대한민국 | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.